CAS: 1616340-94-3
Ref: 4Z-B-167010
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 13 Dec 2024
(2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide-d2, 15N
Controlled ProductCAS:1616340-94-3
Applications (2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide-d2, 15N is an intermediate in the synthesis of Bictegravir-15N, d2 (B382096), which is …
Formula:
C22D2H18F3NN2O5
Color and Shape:
Neat
Molecular weight:
466.412
Ref: TR-M262872
25mg | 2,178.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
(2R,5S,13aR)-8-Methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][ 1,3]oxazepine-10-carboxamide
CAS:1616340-94-3
Please enquire for more information about (2R,5S,13aR)-8-Methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][ 1,3]oxazepine-10-carboxamide including the price, delivery time and more …
Formula:
C22H20F3N3O5
Purity:
Min. 95%
Molecular weight:
463.4 g/mol
Ref: 3D-RPC34094
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |